Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 97, Issue 4, 2000, Pages 304-309

  Vaughan, Carl J ^b   Basson, Craig T ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

Atrial septal defect; EVC; Genetics; NKX2.5; Patent ductus arteriosus; TBX5; TFAP2B; Transcription factor; Ventricular septal defect

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CARDIOVASCULAR MALFORMATION; ELLIS VAN CREVELD SYNDROME; GENETIC ANALYSIS; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HEREDITY; HOLT ORAM SYNDROME; LIMB DEFORMITY; LIMB MALFORMATION; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; REVIEW;

EID: 0034445182     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8628(200024)97:4<304::aid-ajmg1281>3.0.co;2-%23     Document Type: Review

References (56)

1. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucherlapati R, Seidman JG, Seidman CE. 1997. Mutations in human cause limb and cardiac malformations in Holt-Oram syndrome. Nat Genet 15:30-35.
2. Basson CT, Cowley GS, Solomon SD, Weissman B, Poznanski AK, Traill TA, Seidman JG, Seidman CE. 1994. The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med 330:885-891.
3. Basson CT, Huang T, Lin RC, Bachinsky DR, Weremowicz S, Vaglios A, Bruzzone R, Quadrelli R, Lerone M, Romeo G, Silengo M, Pereira A, Krieger J, Mesquita SF, Kamisago M, Morton CC, Pierpont MEM, Muller CW, Seidman JG, Seidman CE. 1999. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci USA 96: 2919-2924.
4. Benson DW, Basson CT, MacRae CA. 1996. New understandings in the genetics of congenital heart disease. Curr Opin Pediatr 8:505-511.
5. Benson DW, Silberbach GM, Kavanaugh-McHugh A, Cottrill C, Zhang Y, Riggs S, Smalls O, Johnson MC, Watson MS, Seidman JG, Seidman CE, Plowden J, Kugler JD. 1999. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 104:1567-1573.
6. Biben C, Weber R, Kesteven S, Stanley E, McDonald L, Elliott DA, Barnett L, Koentgen F, Robb L, Feneley M, Harvey RP. 2000. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2.5. Circ Res 87:888-895.
7. Chapman DL, Garvey N, Hancock S, Alexiou M, Agulnik SI, Gibson-Brown JJ, Cebra-Thomas J, Bollag RG, Silver LM, Papaioannou VE. 1996. Expression of the T-box family genes, Tbx 1-Tbx 5, during early mouse development. Dev Dyn 206:370-390.
8. Char F. 1978. Peculiar facies with short philtrum, duck-bill lips, ptosis, and low-set ears: a new syndrome? Birth Defects 14:303-305.
9. Cousineau AJ, Lauer RM, Pierpont M, Burns TL, Ardinger RH, Patil SR, Sheffield VC. 1994. Linkage analysis of autosomal dominant atrioventricular canal defects: exclusion of chromosome 21. Hum Genet 93:103-108.
10. Cross SJ, Ching Y-H, Li QY, Armstrong-Buisseret L, Spranger S, Lyonnet S, Bonnet D, Penttinen M, Jonveaux P, Leheup B, Mortier G, Van Ravenswaaij C, Gardiner C-A, Brook JD, Newbury-Ecob R. 2000. The mutation spectrum in Holt-Oram syndrome. J Med Genet 37:785-787.
11. Dixon JW, Costa T, Teshima IE. 1993. Mosaicism for duplication 12q (12q13-q24.2) in a dysmorphic male infant. J Med Genet 30:70-72.
12. Elek C, Marta V, Czeizel E. 1991. Holt-Oram syndroma. Orvosi Heitlap 132:72-78.
13. Ellis RWB, Van Creveld S. 1940. A syndrome characterized by ectodermal dysplasia, polydactyly, chondrodysplasia, and congenital morbus cordis: report of three cases. Arch Dis Child 15:65.
14. Ferencz C, Rubin JD, Loffredo CA, Magee CA. 1993. Epidemiology of congenital heart disease: the Baltimore-Washington Infant Study, 1981-1989. Mt. Kisko, NY: Futura Publishing Co.
15. Gall JC, Stern AM, Cohen MM, Adams MS, Davidson RT. 1966. Holt-Oram syndrome: clinical and genetic study of a large family. Am J Hum Genet 18:187-200.
16. Goldmuntz E, Hoess KB, Kenton ML, Geiger EL, Benson DW. 2000. NKX2.5 mutations in patients with tetralogy of Fallot. Pediatr Res 47:43A.
17. Hatcher CJ, Goldstein MM, Mah CS, Delia CS, Basson CT. 2000. Identification and localization of TBX5 transcription factor during cardiac morphogenesis. Dev Dyn 219:90-95.
18. Herrmann BG, Kispert A. 1994. The T box in embryogenesis. Trends Genet 10:280-286.
19. Holt M, Oram S. 1960. Familial heart disease with skeletal malformations. Br Heart J 22:236-242.
20. Hoffman JI. 1990. Congenital heart disease: incidence and inheritance. Pediatr Clin North Am 37:25-43.
21. Hurst JA, Hall CM, Baraitser M. 1991. The Holt-Oram syndrome. J Med Genet 28:406-410.
22. Kim MS, Hatcher CJ, Wong B, Goldstein MM, Mikawa T, Basson CT. 2000. Tbx5 transcription factor: a cellular arrest signal during vertebrate cardiogenesis. Circulation 102:100-110.
23. Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, Gerwehr S, Carpenter N, Daumer C, Dignan P, Disteche C, Graham JM Jr, Hugdins L, McGillivray B, Miyazaki K, Ogasawara N, Park JP, Pagon R, Pueschel S, Sack G, Say B, Schuffenhauer S, Soukup S, Yamanaka T. 1994. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA 91:4997-5001.
24. Kullmann F, Grimm T. 1993. Holt-Oram-Syndrom. Dtsch Med Wschr 118:1455-1462.
25. Letts RM, Chudley AE, Cumming G, Shokier MH. 1975. The upper limb-cardiovascular syndrome (Holt-Oram syndrome). Clin Orthop Rel Res 116:149-154.
26. Lewis KB, Bruce RA, Baum D, Motulsky AG. 1965. The upper limb-cardiovascular syndrome: an autosomal dominant genetic effect on embryogenesis. JAMA 193: 1080-1086.
27. Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, Yi CH, Gebuhr T, Bullen PJ, Robson SC, Strachan T, Bonnet D, Lyonnet S, Young ID, Raeburn JA, Buckler AJ, Law DJ, Newbury-Ecob RA, Leanage R, Raeburn JA, Young ID. 1997. Holt-Oram syndrome: a clinical genetic study. J Med Genet 33:300-307.
28. Liberatore CM, Searcy-Schrick RD, Yutzey KE. 2000. Ventricular expression of tbx 5 inhibits normal heart chamber development. Dev Biol 223:169-180.
29. Luscher B, Mitchell PJ, Williams T, Tjian R. 1989. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev 3:1507-1517.
30. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP. 1995. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeobox gene Nkx2.5. Genes Dev 9:1654-1666.
31. McKusick VA, Egeland JA, Eldridge R, Krusen DE. 1964. Dwarfism in the Amish. I. The Ellis-van Creveld syndrome. Bull Johns Hopkins Hosp 115:306.
32. Mani A, Lynch HT, Begleiter ML, Porter TR, Rezaie T, Lifton RP. 1998. Mapping a gene for autosomal dominant patent ductus arteriosus. Circulation 98:1-596.
33. McCorquodale MM, Rolf J, Ruppert ES, Kurczynski TW, Kolacki P. 1986. Duplication (12q) syndrome in female cousins, resulting from maternal (11;12)(p15.5;q24.2) translocations. Am J Med Genet 24:613-622.
34. Melnyk AR, Weiss L, Van Dyke DL, Jarvi P. 1981. Malformation syndrome of duplication 12q24.1-qter. Am J Med Genet 10:357-365.
35. Muller CW, Herrmann BG. 1997. Crystallographic structure of the T domain-DNA complex of brachyury transcription factor. Nature 389:884-888.
36. Mullins CE, Pagotto L. 1998. Patent ductus arteriosus. In: Garson AJ, Bricker JT, Fisher DJ, Neish SR, editors. The science and practice of pediatric cardiology. Baltimore: Williams and Wilkins. p 1181-1197.
37. Newbury-Ecob RA, Leanage R, Raeburn JA, Young ID. 1996. Holt-Oram syndrome: a clinical genetic study. J Med Genet 33:300-307.
38. Nora JJ, Nora AH. 1988. Update on counseling the family with a first degree relative with congenital heart defects. Am J Med Genet 29:137-142.
39. Papaioannou VE, Silver LM. 1998. The T-box gene family. BioEssays 20:9-19.
40. Polymeropoulos MH, Ide SE, Wright M, Goodship J, Weissenbach J, Pyeritz RE, Da Silva EO, Ortiz de Luna RI, Francomano CA. 1996. The gene for Ellis-van Creveld syndrome is located on chromosome 4p16. Genomics 35:1-5.
41. Regemorter NV, Haumont D, Kirkpatrick C, Viseur P, Jeanty P, Dodion J, Milaire J, Rooze M, Rodesch F. 1982. Holt-Oram syndrome mistaken for thalidomide embryopathy: embyrological considerations. Eur J Pediatr 138:77-80.
42. Roguin N, Barak M, Bihari SG, Ben-Elisha M. 1996. High prevalence of muscular ventricular septal defect in preterm neonates. Am J Cardiol 78:1183-1185.
43. Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E. 1995. High prevalence of muscular ventricular septal defects in neonates. J Am Coll Cardiol 26:1545-1548.
44. Ruiz-Perez VL, Ide S, Strom TM, Lorenz B, Wilson D, Woods K, King L, Francomano CA, Freisinger P, Spranger S, Marino B, Dallapiccola B, Wright M, Meitinger T, Polymeropoulos MH, Goodship J. 2000. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet 24:283-286.
45. Ruzic B, Bosnar B, Beleznay O. 1981. Ein seltener Herzfehler als Symptom de Holt-Oram Syndroms. Radiologie 21:296-299.
46. Sahn DJ, Goldberg SJ, Allen HD, Canale JM. 1981. Cross sectional echocardiographic imaging of supracardiac total anomalous pulmonary venous drainage to a vertical vein in a patient with Holt-Oram syndrome. Chest 79:113-115.
47. Satoda M, Pierpont MEM, Diaz GA, Gelb BD. 1999. Char syndrome, an inherited disorder with patent ductus arteriosus, maps to chromosome 6p12-p21. Circulation 99:3036-3042.
48. Satoda M, Zhao F, Diaz GA, Burn J, Goodship J, Davidson HR, Pierpont MEM, Gelb BD. 2000. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet 25:42-46.
49. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. 1998. Congenital heart disease caused by mutations in the transcription factor NKX2.5. Science 281:108-111.
50. Sheffield VC, Pierpont ME, Nishimura D, Beck JS, Burns L, Berg MA, Stone EM, Patil SR, Lauer RM. 1997. Identification of a complex congenital heart defect susceptibility locus by using DNA pooling and shared segment analysis. Hum Mol Genet 6:117-121.
51. Smith AT, Sack GH, Taylor GJ. 1979. Holt-Oram syndrome. J Pediatr 95:538-543.
52. Starke H, Schimke RN, Dunn M. 1967. Upper-limb cardiovascular syndrome: a family study. Am J Cardiol 19:588-592.
53. Tanaka M, Berul CI, Douglas PS, Mudd JO, Seidman CE, Seidman JG, Izumo S. 1999. A mouse model for familial atrial septal defect associated with arrhythmia generated by gene targeting of the cardiac transcription factor Csx/Nkx2.5. Circulation 100:I59.
54. Tanaka M, Chen Z, Bartunkova S, Yamasaki N, Izumo S. 1999. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126:1269-1280.
55. Yang J, Hu D, Xia J, Yang Y, Ying B, Hu J, Zhou Z. 2000. Three novel TBX5 mutations in Chinese patients with Holt-Oram syndrome. Am J Med Genet 92:237-240.
56. Zhang KZ, Sun QB, Cheng TO. 1986. Holt-Oram syndrome in China: a collective review of 18 cases. Am Heart J 111:572-577.